Novo Nordisk, the once-untouchable king of the weight-loss empire, is having a full-blown meltdown because Hims & Hers just dropped a budget knockoff of their precious Wegovy pill for a measly $49 (before it sneakily climbs to $99). The pharma giant is screaming “illegal compounding!” and threatening lawsuits like a jilted ex, while their stock does the cha-cha—down 8%, up 5% after the FDA swoops in like a protective big brother. Meanwhile, Eli Lilly is laughing all the way to the trillion-dollar club, proving that in the battle of the bulge drugs, cheap copies might just be the real slim shady stealing the show.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
